Skip to main content
. 2016 Jan 6;12:27. doi: 10.1007/s11306-015-0930-4

Table 3.

Metabolites with a significant unadjusted interaction with medication group on relative HbA1c change among patients with HbA1c > 6.5 %

Metformin Sulphonylurea (SU) Metformin and SU
Coefficient p-value Coefficient p-value Coefficient p-value
Glucose (HMDB 00122, CAS 50-99-7) −2.7 0.0003 −2.2 0.012 −2.8 0.0002
Glutamic acid internal amide (HMDB 00267, CAS 98-79-3) 39.1 0.001 28.1 0.042 29.5 0.009
1,5 anhydroglucitol (HMDB 02712, CAS 154-58-5) 23.7 0.003 21.2 0.018 42.4 <0.0001
4-hydroxyglutamate semialdehyde (HMDB 06556) 1327.7 0.007 1219.7 0.030 1180.1 0.018
2-hydroxybutanoic acid (HMDB 00008, CAS 5094-24-6) −85.8 0.009 −6.5 0.898 −110.6 0.002
3-amino 2 piperinidon (HMDB 00323, CAS 1892-22-4) −23.2 0.013 −250.8 0.792 −1535.5 0.023
3 hydroxybutanoic acid (HMDB 00357, CAS 300-85-6) −23.2 0.013 −39.4 0.297 −58.3 0.012
4-oxoproline (KEGG C01877, CAS 4347-18-6) 464.6 0.029 224.7 0.477 576.8 0.022
2-hydroxypiperidine (Pubchem 24847875, CAS 5382-16-1) 1126.4 0.045 696.3 0.319 1283.3 0.033
Xanthine (HMDB 00292, CAS 69-89-6) 2086.6 0.501 −4215.6 0.261 −8405.6 0.004
C20:1 fatty acid (HMDB 02231, CAS 26764-41-0) −1590.6 0.103 −1724.4 0.176 −2701.4 0.009
C14:0 fatty acid (HMDB 00806, CAS 544-63-8) −267.3 0.243 −219.4 0.534 −527.4 0.026
C18:0 fatty acid (HMDB 00827, CAS 57-11-4) −804 0.231 −27.1 0.771 −145.8 0.030
C17:0 fatty acid (HMDB 02259, CAS 506-12-7) −1273.0 0.476 368.5 0.880 −3742.5 0.039
Mannose (HMDB 00169, CAS 3458-28-4) −58.5 0.425 −13.2 0.898 −152.6 0.042
LCB 18:1-17:0 SM 1348.7 0.090 675.3 0.493 1702.6 0.043
Myo-inositol (HMDB 00211, CAS 87-89-8) 53.1 0.083 −12.2 0.735 67.2 0.044
LCB 18:0-16:0 SM (HMDB 10168) 61.8 0.217 67.8 0.351 105.4 0.046
Fumaric acid (HMDB 00134, CAS 110-17-8) −979.8 0.266 −2234.0 0.044 −926.0 0.329